Aclaris Therapeutics, Inc. (FRA:8AT)

Aclaris Therapeutics Revenue

Aclaris Therapeutics had revenue of $3.30M USD in the quarter ending September 30, 2025, a decrease of -24.09%. This brings the company's revenue in the last twelve months to $15.74M, down -41.87% year-over-year. In the year 2024, Aclaris Therapeutics had annual revenue of $18.72M, down -40.09%.

• Revenue (ttm): $15.74M
• Revenue Growth: -41.87%
• P/S Ratio: 23.86
• Revenue / Employee: $245.97K
• Employees: 64
• Market Cap: 320.09M EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	18.72M	-12.53M	-40.09%
Dec 31, 2023	31.25M	1.50M	5.03%
Dec 31, 2022	29.75M	22.99M	340.05%
Dec 31, 2021	6.76M	279.00K	4.30%
Dec 31, 2020	6.48M	2.26M	53.35%
Dec 31, 2019	4.23M	-1.92M	-31.28%
Dec 31, 2018	6.15M	4.47M	265.48%
Dec 31, 2017	1.68M	-	-
Dec 31, 2016	-	-	-
Dec 31, 2015	-	-	-
Dec 31, 2014	-	-	-
Dec 31, 2013	-	-	-